Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-16 4:01 pm Purchase | 2022-11-14 | 13G | CUE BIOPHARMA INC CUE | STROME MARK E | 72,208 4.990% | 45,854 (+173.99%) | Filing History |
| 2025-03-21 7:14 pm Unchanged | 2025-03-19 | 13G | CUE BIOPHARMA INC CUE | Bleichroeder LP | 204,255 9.990% | 0 (Unchanged) | Filing History |
| 2025-02-14 5:00 pm Sale | 2024-12-31 | 13G | CUE BIOPHARMA INC CUE | Slate Path Capital LP | 30,628 1.400% | -49,454 (-61.75%) | Filing History |
| 2024-10-07 5:07 pm Purchase | 2024-09-30 | 13G | CUE BIOPHARMA INC CUE | Bleichroeder LP | 204,255 9.990% | 112,421 (+122.42%) | Filing History |
| 2024-03-11 6:40 pm Purchase | 2024-02-27 | 13G | CUE BIOPHARMA INC CUE | Bleichroeder LP | 91,834 6.110% | 91,834 (New Position) | Filing History |
| 2024-02-07 5:09 pm Sale | 2024-01-31 | 13G | CUE BIOPHARMA INC CUE | BlackRock Inc. BLK | 74,933 4.980% | -3,026 (-3.88%) | Filing History |
| 2024-01-31 2:08 pm Purchase | 2023-12-31 | 13G | CUE BIOPHARMA INC CUE | BlackRock Inc. BLK | 77,959 5.200% | 50,228 (+181.13%) | Filing History |
| 2023-02-14 09:30 am Unchanged | 2022-12-31 | 13G | CUE BIOPHARMA INC CUE | Slate Path Capital LP | 80,082 5.600% | 0 (Unchanged) | Filing History |
| 2023-02-03 11:36 am Sale | 2022-12-31 | 13G | CUE BIOPHARMA INC CUE | STATE STREET CORP STT | 4,705 0.330% | -50,703 (-91.51%) | Filing History |
| 2022-12-02 5:21 pm Sale | 2022-12-01 | 13G | CUE BIOPHARMA INC CUE | Nantahala Capital Management, LLC | 3,110 0.300% | -81,547 (-96.33%) | Filing History |
| 2022-11-18 4:04 pm Purchase | 2022-11-16 | 13G | CUE BIOPHARMA INC CUE | Slate Path Capital LP | 80,082 5.600% | 80,082 (New Position) | Filing History |
| 2022-07-08 4:57 pm Sale | 2022-06-30 | 13G | CUE BIOPHARMA INC CUE | BlackRock Inc. BLK | 27,731 2.400% | -48,611 (-63.68%) | Filing History |
| 2022-02-14 4:23 pm Sale | 2021-12-31 | 13G | CUE BIOPHARMA INC CUE | Corriente Advisors LLC | 0 0.000% | -63,841 (Position Closed) | Filing History |
| 2022-02-14 08:09 am Purchase | 2021-12-31 | 13G | CUE BIOPHARMA INC CUE | Nantahala Capital Management, LLC | 84,657 8.000% | 1,098 (+1.31%) | Filing History |
| 2022-02-10 1:52 pm Purchase | 2021-12-31 | 13G | CUE BIOPHARMA INC CUE | STATE STREET CORP STT | 55,408 5.230% | 55,408 (New Position) | Filing History |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | CUE BIOPHARMA INC CUE | BlackRock Inc. BLK | 76,342 7.200% | 4,243 (+5.88%) | Filing History |